See All Slides - tctmd.com

Slides

Presentation TCT 2012

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Retrograde Approach to a Complex Chronic Total Occlusion

Presenter: Bin Zhang

October 24, 2012

Presentation TCT 2012

Obstructive Sleep Apnea

Presenter: Adam Witkowski

October 24, 2012

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

Radial Circulation: Do We Need to Check for Dual Circulation of the Hand Before Accessing the Radial Artery?

Presenter: Ian Gilchrist

October 23, 2012

Presentation TCT 2012

Hybrid Revascularization: The University of Maryland Approach

Presenter: Mark Vesely

October 23, 2012

Presentation TCT 2012

ELM Presentation(4)

Presenter: Allen Jeremias

October 23, 2012

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Presenter: Fayaz Shawl

October 23, 2012

Presentation TCT 2012

ELM Presentation(9)

Presenter: Jennifer Tremmel

October 23, 2012

Advertisement

Slides

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

Retrograde Approach to a Complex Chronic Total Occlusion

Obstructive Sleep Apnea

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Radial Circulation: Do We Need to Check for Dual Circulation of the Hand Before Accessing the Radial Artery?

Hybrid Revascularization: The University of Maryland Approach

ELM Presentation(4)

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

ELM Presentation(9)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content